Abstract
OBJECTIVE: To investigate whether low serum cholesterol concentration or changing serum cholesterol concentration is associated with risk of suicide in men. DESIGN: Cohort study with annual repeat measurements of serum cholesterol concentration (for up to four years). SETTING: Paris, France. SUBJECTS: 6393 working men, aged 43-52 in 1967-72, who had at least three measurements of serum cholesterol concentration. MAIN OUTCOME MEASURES: Individual change over time in serum cholesterol concentration (estimated using within person linear regression method); death from suicide during average of 17 years' follow up after last examination. RESULTS: 32 men committed suicide during follow up. After adjustment for age and other factors, relative risk of suicide for men with low average serum cholesterol concentration (< 4.78 mmol/l) compared with those with average serum cholesterol concentration of 4.78-6.21 mmol/l was 3.16 (95% confidence interval 1.38 to 7.22, P = 0.007). Men whose serum cholesterol concentration decreased by more than 0.13 mmol/l a year had multivariate adjusted relative risk of 2.17 (0.97 to 4.84, P = 0.056) compared with those whose cholesterol remained stable (change of < or = 0.13 mmol/l a year). CONCLUSION: Both low serum cholesterol concentration and declining cholesterol concentration were associated with increased risk of death from suicide in men. Although there is some evidence in favour of a concomitant rather than a causal effect for interpreting these associations, long term surveillance of subjects included in trials of lipid lowering treatments seems warranted.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Engelberg H. Low serum cholesterol and suicide. Lancet. 1992 Mar 21;339(8795):727–729. doi: 10.1016/0140-6736(92)90609-7. [DOI] [PubMed] [Google Scholar]
- Gallerani M., Manfredini R., Caracciolo S., Scapoli C., Molinari S., Fersini C. Serum cholesterol concentrations in parasuicide. BMJ. 1995 Jun 24;310(6995):1632–1636. doi: 10.1136/bmj.310.6995.1632. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Law M. R., Thompson S. G., Wald N. J. Assessing possible hazards of reducing serum cholesterol. BMJ. 1994 Feb 5;308(6925):373–379. doi: 10.1136/bmj.308.6925.373. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Law M. R., Wald N. J. Serum cholesterol concentrations in parasuicide. Depression may cause low cholesterol. BMJ. 1995 Sep 23;311(7008):807–807. doi: 10.1136/bmj.311.7008.807a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lecomte D., Hatton F., Jougla E., Le Toullec A. Le suicide à Paris et en Ile-de-France. Encephale. 1995 Jan-Feb;21(1):41–49. [PubMed] [Google Scholar]
- Magni G., Garreau M., Orofiamma B., Palminteri R. Fengabine, a new GABAmimetic agent in the treatment of depressive disorders: an overview of six double-blind studies versus tricyclics. Neuropsychobiology. 1989;20(3):126–131. doi: 10.1159/000118485. [DOI] [PubMed] [Google Scholar]
- Muldoon M. F., Manuck S. B., Matthews K. A. Lowering cholesterol concentrations and mortality: a quantitative review of primary prevention trials. BMJ. 1990 Aug 11;301(6747):309–314. doi: 10.1136/bmj.301.6747.309. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Shepherd J., Cobbe S. M., Ford I., Isles C. G., Lorimer A. R., MacFarlane P. W., McKillop J. H., Packard C. J. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995 Nov 16;333(20):1301–1307. doi: 10.1056/NEJM199511163332001. [DOI] [PubMed] [Google Scholar]
- Steegmans P. H., Fekkes D., Hoes A. W., Bak A. A., van der Does E., Grobbee D. E. Low serum cholesterol concentration and serotonin metabolism in men. BMJ. 1996 Jan 27;312(7025):221–221. doi: 10.1136/bmj.312.7025.221. [DOI] [PMC free article] [PubMed] [Google Scholar]